Hck promotes IL-1β-induced extracellular matrix degradation, inflammation, and apoptosis in osteoarthritis via activation of the JAK-STAT3 signaling pathway

Bernard NJ. 2018. Fyn-ding a target for OA therapy. Nature Reviews Rheumatology 14: 322– 22.

Bursell L, Woods A, James CG, Pala D, Leask A, Beier F. Src kinase inhibition promotes the chondrocyte phenotype. Arthritis Res Ther. 2007;9:R105.

Article  PubMed  PubMed Central  Google Scholar 

Chen M, Menon MC, Wang W, Fu J, Yi Z, et al. HCK induces macrophage activation to promote renal inflammation and fibrosis via suppression of autophagy. Nat Commun. 2023;14:4297.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dias MH, Friskes A, Wang S, Fernandes Neto JM, van Gemert F, et al. Paradoxical activation of oncogenic signaling as a cancer treatment strategy. Cancer Discov. 2024;14:1276–301.

Article  PubMed  PubMed Central  Google Scholar 

Dorotea D, Jiang S, Pak ES, Son JB, Choi HG, et al. Pan-src kinase inhibitor treatment attenuates diabetic kidney injury via inhibition of fyn kinase-mediated endoplasmic reticulum stress. Exp Mol Med. 2022;54:1086–97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fazio A, Di Martino A, Brunello M, Traina F, Marvi MV, et al. The involvement of signaling pathways in the pathogenesis of osteoarthritis: an update. J Orthop Translation. 2024;47:116–24.

Article  Google Scholar 

Felson DT. Identifying different osteoarthritis phenotypes through epidemiology. Osteoarthritis Cartilage. 2010;18:601–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng X, Xue F, He G, Ni Q, Huang S. 2021. Banxia xiexin decoction affects drug sensitivity in gastric cancer cells by regulating MGMT expression via IL–6/JAK/STAT3–mediated PD–L1 activity. Int J Mol Med 48.

Guo SM, Wang JX, Li J, Xu FY, Wei Q, et al. Identification of gene expression profiles and key genes in subchondral bone of osteoarthritis using weighted gene coexpression network analysis. J Cell Biochem. 2018;119:7687–95.

Article  CAS  PubMed  Google Scholar 

Hodgkinson T, Kelly DC, Curtin CM, O’Brien FJ. Mechanosignalling in cartilage: an emerging target for the treatment of osteoarthritis. Nat Rev Rheumatol. 2022;18:67–84.

Article  PubMed  Google Scholar 

Hu X, Ji X, Yang M, Fan S, Wang J, et al. Cdc42 is essential for both articular cartilage degeneration and subchondral bone deterioration in experimental osteoarthritis. J Bone Min Res. 2018;33:945–58.

Article  CAS  Google Scholar 

Issa RI, Griffin TM. 2012. Pathobiology of obesity and osteoarthritis: integrating biomechanics and inflammation. Pathobiology Aging age Relat Dis 2.

Johnson DE, O’Keefe RA, Grandis JR. Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15:234–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim Y, Hayashi M, Ono T, Yoda T, Takayanagi H, Nakashima T. Suppression of hematopoietic cell kinase ameliorates the bone destruction associated with inflammation. Mod Rheumatol. 2020;30:85–92.

Article  CAS  PubMed  Google Scholar 

Li H, Zhao C, Tian Y, Lu J, Zhang G, et al. Src family kinases and pulmonary fibrosis: a review. Biomed Pharmacother. 2020;127:110183.

Article  CAS  PubMed  Google Scholar 

Li Z, Wang F, Tian X, Long J, Ling B, et al. HCK maintains the self-renewal of leukaemia stem cells via CDK6 in AML. J Exp Clin Cancer Res. 2021;40:210.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo S, Du S, Tao M, Cao J, Cheng P. Insights on hematopoietic cell kinase: an oncogenic player in human cancer. Biomed Pharmacother. 2023;160:114339.

Article  CAS  PubMed  Google Scholar 

Malemud CJ. 2017. Negative regulators of JAK/STAT signaling in rheumatoid arthritis and osteoarthritis. Int J Mol Sci 18.

Maniar KH, Jones IA, Gopalakrishna R, Vangsness CT Jr. Lowering side effects of NSAID usage in osteoarthritis: recent attempts at minimizing dosage. Expert Opin Pharmacother. 2018;19:93–102.

Article  CAS  PubMed  Google Scholar 

Mocanu V, Timofte DV, Zară-Dănceanu CM, Labusca L. 2024. Obesity, Metabolic syndrome, and osteoarthritis require integrative understanding and management. Biomedicines 12.

Mukherjee A, Das B. The role of inflammatory mediators and matrix metalloproteinases (MMPs) in the progression of osteoarthritis. Biomaterials Biosystems. 2024;13:100090.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Musumeci F, Schenone S, Brullo C, Desogus A, Botta L, Tintori C. Hck inhibitors as potential therapeutic agents in cancer and HIV infection. Curr Med Chem. 2015;22:1540–64.

Article  CAS  PubMed  Google Scholar 

Poh AR, O’Donoghue RJ, Ernst M. Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells. Oncotarget. 2015;6:15752–71.

Article  PubMed  PubMed Central  Google Scholar 

Poh AR, Love CG, Masson F, Preaudet A, Tsui C et al. 2017. Inhibition of hematopoietic cell kinase activity suppresses myeloid cell-mediated Colon cancer progression. Cancer Cell 31: 563– 75.e5.

Poh AR, Dwyer AR, Eissmann MF, Chand AL, Baloyan D, et al. Inhibition of the SRC kinase HCK impairs STAT3-Dependent gastric tumor growth in mice. Cancer Immunol Res. 2020;8:428–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Poh AR, Love CG, Chisanga D, Steer JH, Baloyan D, et al. Therapeutic inhibition of the SRC-kinase HCK facilitates T cell tumor infiltration and improves response to immunotherapy. Sci Adv. 2022;8:eabl7882.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage. 2006;14:13–29.

Article  CAS  PubMed  Google Scholar 

Roversi FM, Bueno MLP, da Silva JAF, Assis-Mendonça GR, Torello CO, et al. Novel inhibitor of hematopoietic cell kinase as a potential therapeutic agent for acute myeloid leukemia. Cancer Immunol Immunother. 2022;71:1909–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shane Anderson A, Loeser RF. Why is osteoarthritis an age-related disease? Best Pract Res Clin Rheumatol. 2010;24:15–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shouda T, Yoshida T, Hanada T, Wakioka T, Oishi M, et al. Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J Clin Invest. 2001;108:1781–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Urban H, Little CBJR. 2018. The role of fat and inflammation in the pathogenesis and management of osteoarthritis. 57:iv10–21.

van Doormaal MCM, Meerhoff GA, Vliet Vlieland TPM, Peter WF. A clinical practice guideline for physical therapy in patients with hip or knee osteoarthritis. Musculoskelet Care. 2020;18:575–95.

Article  Google Scholar 

Van Opdenbosch N, Lamkanfi M. Caspases in cell death, inflammation, and disease. Immunity. 2019;50:1352–64.

Article  PubMed  PubMed Central  Google Scholar 

Wang T, He C. Pro-inflammatory cytokines: the link between obesity and osteoarthritis. Cytokine Growth Factor Rev. 2018;44:38–50.

Article  PubMed  Google Scholar 

Wang J, Chen R, Liu X, Shen J, Yan Y, et al. Hck promotes neuronal apoptosis following intracerebral hemorrhage. Cell Mol Neurobiol. 2017;37:251–61.

Article  CAS  PubMed  Google Scholar 

Wang X, Ning Y, Zhang P, Poulet B, Huang R, et al. Comparison of the major cell populations among osteoarthritis, Kashin-Beck disease and healthy chondrocytes by single-cell RNA-seq analysis. Cell Death Dis. 2021;12:551.

Article  CAS  PubMed  PubMed Central 

留言 (0)

沒有登入
gif